Although most national obstetrical associations continue to recommend insulin as first-line pharmacotherapy for diabetes in pregnancy given its inability to cross the placenta5,11,25, certain oral glycaemic agents are gaining attention. The gene discussed is INS; the disease is diabetes mellitus.